GMED - GLOBUS MEDICAL INC

GMED

$76.31 +0.07 (+0.09%) Last updated: Oct 13, 2026 19:56

52-Week Range

$76.31

$56.96 $76.31 $101.40

Fundamentals Overview

GLOBUS MEDICAL INC is in the middle of its 52-week range with attractive valuation, trading relatively flat today.

Valuation attractive

P/E 18.7 PEG 0.37 P/B 2.25 P/S 3.19

Profitability

ROE 11.59% Net margin 17%

Risk (Beta)

0.97 — in line vol

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 59% confidence Risk: Moderate Volatility — Beta 0.97. Diversify and only invest what you can afford to lose.

Supporting (Buy):

PEG 0.37 (growth vs price)

Pressures (Sell):

Volume below average

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$10.24B

P/E (TTM)

18.72

EPS (TTM)

N/A

Dividend Yield

N/A

52-Week Range

$56.96 - $101.40

Volume vs Avg

0.35x

35% of avg (Low)

Beta

0.97

About

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from ...

Sector: Healthcare

Headquarters: US

Website: www.globusmedical.com

Beta: 0.97 (Less volatile than market)

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

Metric	Value
Valuation
P/E (TTM)	18.72
PEG (TTM)	0.37
P/B (TTM)	2.25
P/S (TTM)	3.19
Profitability
ROE (TTM)	11.59%
ROA (TTM)	10.04%
Revenue growth (YoY)	N/A
Net margin (TTM)	17.03%
Gross margin (TTM)	68.55%
Operating margin (TTM)	20.6%
Debt to equity (TTM)	0

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for GMED.

Loading analyst coverage...

Price target data is not available for this symbol from the current data source.

Stock Grades (Institutions)

No stock grades available for this symbol.

No price targets, ratings snapshot, or grades available for this symbol.